Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Tobacco | 1,202.5 | 1,204.5 | 1,114.8 | 1,111.1 | 1,081.0 | 1,011.6 | 1,017.8 | 1,021.3 |
Real Estate | 18.2 | 24.2 | 4.8 | 759.2 | 727.4 | 680.1 | 641.4 | 561.5 |
E-Cigarettes | | | | | | | | 8.6 |
Total revenues | 1,220.7 | 1,228.7 | 1,119.6 | 1,870.3 | 1,807.5 | 1,690.9 | 1,657.2 | 1,591.3 |
Revenue growth [+] | -0.6% | 9.7% | -40.1% | 3.5% | 6.9% | 2.0% | 4.1% | 47.4% |
Tobacco | -0.2% | 8.0% | 0.3% | 2.8% | 6.9% | -0.6% | -0.3% | 0.7% |
Real Estate | -24.7% | 407.7% | -99.4% | 4.4% | 6.9% | 6.0% | 14.2% | 756.2% |
Cost of goods sold | 769.5 | 819.6 | 774.9 | 1,292.5 | 1,228.0 | 1,097.3 | 1,109.7 | 1,097.1 |
Gross profit | 451.2 | 409.1 | 344.7 | 577.8 | 579.4 | 593.6 | 547.5 | 494.3 |
Gross margin | 37.0% | 33.3% | 30.8% | 30.9% | 32.1% | 35.1% | 33.0% | 31.1% |
Selling, general and administrative | 131.4 | 116.6 | 109.1 | 355.5 | 337.2 | 339.1 | 320.2 | 279.3 |
Equity in earnings | 10.3 | -44.7 | -27.8 | 14.4 | 21.4 | 5.2 | 2.0 | 3.1 |
EBITDA [+] | 346.3 | 265.4 | 225.7 | 255.5 | 282.2 | 282.1 | 254.9 | 242.6 |
EBITDA growth | 30.5% | 17.6% | -11.7% | -9.5% | 0.1% | 10.7% | 5.1% | 91.1% |
EBITDA margin | 28.4% | 21.6% | 20.2% | 13.7% | 15.6% | 16.7% | 15.4% | 15.2% |
Depreciation | 16.3 | 17.6 | 17.9 | 18.0 | 17.7 | 22.4 | 25.7 | 24.5 |
EBITA | 330.0 | 247.8 | 207.8 | 237.5 | 264.5 | 259.7 | 229.3 | 218.1 |
EBITA margin | 27.0% | 20.2% | 18.6% | 12.7% | 14.6% | 15.4% | 13.8% | 13.7% |
Amortization of intangibles | | | | 0.8 | 0.9 | | | |
EBIT [+] | 330.0 | 247.8 | 207.8 | 236.7 | 263.6 | 259.7 | 229.3 | 218.1 |
EBIT growth | 33.2% | 19.2% | -12.2% | -10.2% | 1.5% | 13.3% | 5.1% | 90.8% |
EBIT margin | 27.0% | 20.2% | 18.6% | 12.7% | 14.6% | 15.4% | 13.8% | 13.7% |
Non-recurring items [+] | -0.7 | -1.9 | 1.0 | -1.8 | 6.6 | 20.0 | 27.3 | 2.5 |
Asset impairment | -0.9 | -2.3 | | | | | | |
Legal settlement | 0.2 | 0.3 | 1.0 | -1.8 | 6.6 | 20.0 | 20.1 | 2.5 |
Interest expense | 112.7 | 121.3 | 137.5 | 203.8 | 173.7 | 143.0 | 120.7 | 161.0 |
Interest expense | 112.7 | 121.3 | 137.5 | 203.8 | 173.7 | 143.0 | 120.7 | 161.0 |
Other income (expense), net [+] | -8.0 | 52.6 | 55.7 | 44.8 | 5.8 | 29.7 | 26.5 | 27.7 |
Realized gain (loss) on investments | | | | | | | 11.1 | 0.0 |
Gain (loss) on debt retirement | -21.4 | | -4.3 | -4.1 | -34.1 | | | |
Other | 10.7 | -8.6 | 16.6 | 0.8 | 4.0 | 4.2 | 17.5 | 9.4 |
Pre-tax income | 210.0 | 181.0 | 125.0 | 79.6 | 89.2 | 126.4 | 107.7 | 82.3 |
Income taxes | 62.8 | 54.1 | 31.1 | 21.6 | -1.6 | 49.2 | 41.2 | 33.2 |
Tax rate | 29.9% | 29.9% | 24.9% | 27.1% | | 38.9% | 38.3% | 40.3% |
Minority interest | 0.2 | | 0.0 | 0.1 | 6.2 | 6.1 | 7.3 | 12.3 |
Earnings from continuing ops | 137.7 | 215.0 | 118.0 | 79.5 | 84.6 | 71.1 | 59.2 | 36.9 |
Earnings from discontinued ops | 72.1 | -34.0 | 7.1 | | | | | |
Net income | 209.8 | 181.0 | 125.1 | 79.5 | 84.6 | 71.1 | 59.2 | 36.9 |
Net margin | 17.2% | 14.7% | 11.2% | 4.2% | 4.7% | 4.2% | 3.6% | 2.3% |
|
Basic EPS [+] | $0.90 | $1.43 | $0.80 | $0.54 | $0.58 | $0.52 | $0.46 | $0.32 |
Growth | -36.9% | 77.9% | 48.2% | -6.3% | 11.4% | 14.1% | 40.4% | -12.2% |
Diluted EPS [+] | $0.90 | $1.43 | $0.80 | $0.54 | $0.58 | $0.52 | $0.46 | $0.32 |
Growth | -36.9% | 78.8% | 47.6% | -6.2% | 11.4% | 13.9% | 40.4% | -12.0% |
|
Dividends per share [+] | $0.80 | $0.80 | $1.54 | $1.47 | $1.40 | $1.40 | $1.40 | $1.40 |
Growth | 0.0% | -48.1% | 4.8% | 5.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
Shares outstanding (basic) [+] | 152.4 | 150.2 | 146.6 | 146.4 | 146.0 | 136.7 | 129.8 | 113.5 |
Growth | 1.5% | 2.4% | 0.2% | 0.3% | 6.8% | 5.3% | 14.4% | 12.5% |
Shares outstanding (diluted) [+] | 152.5 | 150.3 | 147.4 | 146.5 | 146.3 | 137.0 | 129.9 | 113.5 |
Growth | 1.5% | 2.0% | 0.6% | 0.1% | 6.8% | 5.5% | 14.4% | 12.3% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|